Digital Heart Summit 2025: AI and Patient Empowerment Take Center Stage in Cardiology’s Future BIOTRONIK Connects Global Experts to Drive Digital Transformation in Cardiology
At the Digital Heart Summit 2025 in Berlin, 120 leading experts gathered to explore how digital innovation is reshaping cardiovascular care. Organized by BIOTRONIK, the event spotlighted the growing impact of artificial intelligence, real-world data, and patient-centric technologies in redefining diagnostics and treatment strategies.
Discussions highlighted how digital tools are moving toward proactive, preventive care. For the experts, the vision is clear: by integrating AI-driven insights with patient engagement strategies, connected platforms can support informed decision-making across regions and specialties. This shift moves the focus from managing disease to maintaining long-term heart health.
“The combination of AI-driven data and a strong focus on patient empowerment is a key driver of digital transformation in cardiology,” said Prof. Gerhard Hindricks, Department of Cardiology, Angiology and Intensive Care Medicine and Chief Integration Officer at Deutsches Herzzentrum der Charité and chair of the summit. “Our goal must be to create holistic and smart solutions that support prevention and enable both physicians and patients to make evidence-based decisions.”
Adding to this perspective, Dr. Marco Perez, Associate Professor of Medicine at Stanford University and panelist at the event, emphasized the transformative role of advanced algorithms: “Machine learning and large language models are opening new frontiers in the diagnosis and management of atrial fibrillation. By leveraging these technologies, we can identify patterns earlier, personalize treatment, and ultimately improve patient outcomes on a global scale.”
BIOTRONIK showcased its successful implementation of eHealth solutions across multiple markets. In Germany, over 12,000 patients benefit from the inCareNet HF platform, making BIOTRONIK the market leader in digital heart failure care.
The experts explored scalable remote monitoring, digital reimbursement models, and real-world evidence. Studies such as the HERMeS trial demonstrated how digital tools can improve outcomes and streamline care. The participants also tested next-generation sensors, remote device management, and connected platforms.
Despite technological progress, regulatory complexity, fragmented infrastructures, and reimbursement hurdles remain significant barriers to adoption. Successful projects in Europe, Australia, and the US offered roadmaps for overcoming these barriers. “The Digital Heart Summit highlighted the need for innovative solutions in telecardiology. The ideas shared will help shape the future of cardiac care and accelerate eHealth adoption,” concluded Dr. Andreas Hecker, Chief Technology Officer at BIOTRONIK.
-END-
About BIOTRONIK
For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology.
